Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

China · Delayed Price · Currency is CNY

30.71

-1.93 (-5.91%)

At close: Jan 29, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Nucleotide	160.64M
Nucleotide Growth	9.85%
Purine	133.86M
Purine Growth	-8.33%
Pyrimidine	80.38M
Pyrimidine Growth	67.38%
Nucleoside	13.21M
Nucleoside Growth	-97.15%
Other	33.59M
Other Growth	6.78%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	325.00M
China Growth	-56.78%
Overseas	96.69M
Overseas Growth	15.71%